AP
SZYM

Alydar Partners’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Alydar Partners’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-71,187
Closed -$531K – 154
2014
Q3 		$531K Buy
+71,187
New +$665K 0.06% 103
2014
Q1 		– Sell
-150,000
Closed -$1.63M – 139
2013
Q4 		$1.63M Sell
150,000
-100,000
-40% -$984K 0.17% 88
2013
Q3 		$2.7M Buy
250,000
+50,000
+25% +$569K 0.22% 90
2013
Q2 		$2.34M Buy
+200,000
New +$2M 0.13% 91

Other funds holding SZYM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PC
Passport Capital San Francisco, California $394M AUM 50.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T
Tahithromos New York $71.9M AUM 0.24% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Alydar Partners's SZYM Position: Q4 2014 in Review

Alydar Partners sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q4 2014, closing a stake of 71,187 shares — an estimated $531K sold.

Alydar Partners first reported a position in SZYM in Q2 2013 and held it in 4 quarters. The position peaked at $2.7M in Q3 2013. 114 funds tracked by Wall St. Rank hold SZYM as of Q4 2014.

  • Alydar Partners reported no remaining SOLAZYME INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • Alydar Partners sold 71,187 SOLAZYME INC COM STK (DE) shares in Q4 2014, an estimated $531K.
  • Alydar Partners first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 4 quarters.
  • Alydar Partners's SOLAZYME INC COM STK (DE) position peaked at $2.7M in Q3 2013.
  • 114 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q4 2014.

Based on Alydar Partners's 13F filing for Q4 2014, filed 17 Feb 2015.